These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 25358405)
1. Embelin sensitizes acute myeloid leukemia cells to TRAIL through XIAP inhibition and NF-κB inactivation. Yang T; Lan J; Huang Q; Chen X; Sun X; Liu X; Yang P; Jin T; Wang S; Mou X Cell Biochem Biophys; 2015 Jan; 71(1):291-7. PubMed ID: 25358405 [TBL] [Abstract][Full Text] [Related]
2. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells. Mori T; Doi R; Kida A; Nagai K; Kami K; Ito D; Toyoda E; Kawaguchi Y; Uemoto S J Surg Res; 2007 Oct; 142(2):281-6. PubMed ID: 17640673 [TBL] [Abstract][Full Text] [Related]
3. The XIAP inhibitor Embelin enhances TRAIL-induced apoptosis in human leukemia cells by DR4 and DR5 upregulation. Hu R; Yang Y; Liu Z; Jiang H; Zhu K; Li J; Xu W Tumour Biol; 2015 Feb; 36(2):769-77. PubMed ID: 25293521 [TBL] [Abstract][Full Text] [Related]
4. The XIAP inhibitor Embelin enhances TRAIL-mediated apoptosis in malignant glioma cells by down-regulation of the short isoform of FLIP. Siegelin MD; Gaiser T; Siegelin Y Neurochem Int; 2009 Nov; 55(6):423-30. PubMed ID: 19409438 [TBL] [Abstract][Full Text] [Related]
5. Synergism between NF-kappa B inhibitor, celastrol, and XIAP inhibitor, embelin, in an acute myeloid leukemia cell line, HL-60. Pazhang Y; Jaliani HZ; Imani M; Dariushnejad H J Cancer Res Ther; 2016; 12(1):155-60. PubMed ID: 27072230 [TBL] [Abstract][Full Text] [Related]
6. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo. Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553 [TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis. Dai Y; Qiao L; Chan KW; Yang M; Ye J; Ma J; Zou B; Gu Q; Wang J; Pang R; Lan HY; Wong BC Cancer Res; 2009 Jun; 69(11):4776-83. PubMed ID: 19458067 [TBL] [Abstract][Full Text] [Related]
8. XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells. Allensworth JL; Aird KM; Aldrich AJ; Batinic-Haberle I; Devi GR Mol Cancer Ther; 2012 Jul; 11(7):1518-27. PubMed ID: 22508521 [TBL] [Abstract][Full Text] [Related]
9. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis. Kim HS; Chang I; Kim JY; Choi KH; Lee MS Cancer Res; 2005 Jul; 65(14):6111-9. PubMed ID: 16024612 [TBL] [Abstract][Full Text] [Related]
10. X-linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery. Zhou J; Lu X; Tan TZ; Chng WJ Mol Oncol; 2018 Jan; 12(1):33-47. PubMed ID: 29063676 [TBL] [Abstract][Full Text] [Related]
11. Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma. Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Bhanot U; Hasel C; Möller P; Gschwend JE; Simmet T; Debatin KM; Fulda S Cancer Res; 2009 Mar; 69(6):2425-34. PubMed ID: 19258513 [TBL] [Abstract][Full Text] [Related]
12. Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells. Braeuer SJ; Büneker C; Mohr A; Zwacka RM Mol Cancer Res; 2006 Oct; 4(10):715-28. PubMed ID: 17050666 [TBL] [Abstract][Full Text] [Related]
13. Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-κB and PI3K/Akt signaling pathways. Thanaketpaisarn O; Waiwut P; Sakurai H; Saiki I Int J Oncol; 2011 Jul; 39(1):279-85. PubMed ID: 21537836 [TBL] [Abstract][Full Text] [Related]
14. Embelin potentiates venetoclax-induced apoptosis in acute myeloid leukemia cells. Reis-Silva CSM; Branco PC; Lima K; Silva FL; Moreno PRH; Guallar V; Costa-Lotufo LV; Machado-Neto JA Toxicol In Vitro; 2021 Oct; 76():105207. PubMed ID: 34216723 [TBL] [Abstract][Full Text] [Related]
15. Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice. Naumann U; Bähr O; Wolburg H; Altenberend S; Wick W; Liston P; Ashkenazi A; Weller M Gene Ther; 2007 Jan; 14(2):147-61. PubMed ID: 16957768 [TBL] [Abstract][Full Text] [Related]
16. Rocaglamide and a XIAP inhibitor cooperatively sensitize TRAIL-mediated apoptosis in Hodgkin's lymphomas. Giaisi M; Köhler R; Fulda S; Krammer PH; Li-Weber M Int J Cancer; 2012 Aug; 131(4):1003-8. PubMed ID: 21952919 [TBL] [Abstract][Full Text] [Related]
17. Effect of Embelin on TRAIL receptor 2 mAb-induced apoptosis of TRAIL-resistant A549 non-small cell lung cancer cells. Jiang L; Hao JL; Jin ML; Zhang YG; Wei P Asian Pac J Cancer Prev; 2013; 14(10):6115-20. PubMed ID: 24289635 [TBL] [Abstract][Full Text] [Related]
18. Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation. Lee KY; Park JS; Jee YK; Rosen GD Exp Mol Med; 2002 Dec; 34(6):462-8. PubMed ID: 12526088 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells. Lee TJ; Jang JH; Noh HJ; Park EJ; Choi KS; Kwon TK J Cell Biochem; 2010 Apr; 109(5):885-95. PubMed ID: 20127709 [TBL] [Abstract][Full Text] [Related]
20. Sensitization of melanoma cells to TRAIL by UVB-induced and NF-kappaB-mediated downregulation of xIAP. Thayaparasingham B; Kunz A; Peters N; Kulms D Oncogene; 2009 Jan; 28(3):345-62. PubMed ID: 18978816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]